Isolation of Circulating MicroRNAs from Microvesicles Found in Human Plasma
Intact miRNAs can be isolated from the circulation in significant quantities despite the presence of extremely high levels of RNase activity. The remarkable stability of circulating miRNAs makes them excellent candidates for biomarkers in diagnostic applications as well as therapeutic targets in a variety of disease states including melanoma. Circulating RNA molecules are resistant to degradation by RNases because they are encapsulated in membrane-bound microvesicles. We describe a convenient method for the use of ExoQuick, a proprietary resin developed by Systems Biosciences (Mountain View, CA), whereby microvesicles can be purified under gentle conditions using readily available laboratory equipment. This protocol allows for isolation all microvesicles, regardless of their origin, and provides a convenient method for identifying potential cancer-specific biomarkers from biological fluids including serum and plasma.
- Emerging Clinical Issues in Melanoma in the Molecularly Targeted Era
- Fluorescence In Situ Hybridization Methods and Troubleshooting Applied to Fixed Cell Suspensions
- Identifying Genes Related to Chemosensitivity Using Support Vector Machine
- Assaying Cdc25 Phosphatase Activity
- Molecular Characterization of STAT Signaling in Inflammation and Tumorigenesis
- Cell Aggregation Assays
- Comparative Multiplex PCR and Allele-Specific Expression Analysis in Human Lung Cancer: Tools to Facilitate Target Identificatio
- 用LIPO2000转染HepG2细胞的问题
- MHC 四聚体助力细胞治疗基础研究:CTL 表位筛选
- PPARγ基因的序列